Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Syros Pharmaceuticals (NQ: SYRS ) 5.160 -0.570 (-9.95%) Streaming Delayed Price Updated: 4:00 PM EDT, Jun 28, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Headline News about Syros Pharmaceuticals < Previous 1 2 3 4 5 6 Next > SYRS Stock Earnings: Syros Pharmaceuticals Beats EPS for Q1 2024 May 14, 2024 SYRS stock results show that Syros Pharmaceuticals beat analyst estimates for earnings per share the first quarter of 2024. Via InvestorPlace Crude Oil Down Over 1%; Cognyte Software Shares Plummet April 09, 2024 U.S. stocks traded lower toward the end of trading, with the S&P 500 falling around 0.4% on Tuesday. The Dow traded down 0.46% to 38,713.72 while the NASDAQ fell 0.24% to 16,215.32. The S&P 500 also... Via Benzinga Topics Stocks Exposures Fossil Fuels US Equities Why Tilray Brands Shares Are Trading Lower By Around 22%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session April 09, 2024 Shares of Tilray Brands, Inc. (NASDAQ: TLRY) fell sharply during Tuesday’s session after the company missed third-quarter estimates and said it no longer expects to generate positive adjusted free Via Benzinga Syros Pharmaceuticals's Earnings Outlook March 26, 2024 Via Benzinga Preview: Syros Pharmaceuticals's Earnings November 13, 2023 Via Benzinga Earnings Outlook For Syros Pharmaceuticals August 07, 2023 Via Benzinga 12 Health Care Stocks Moving In Tuesday's Intraday Session April 09, 2024 Via Benzinga Top 3 Health Care Stocks You'll Regret Missing This Month April 02, 2024 The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies. Via Benzinga SYRS Stock Earnings: Syros Pharmaceuticals Misses EPS, Misses Revenue for Q4 2023 March 27, 2024 SYRS stock results show that Syros Pharmaceuticals missed analyst estimates for earnings per share and missed on revenue for the fourth quarter of 2023. Via InvestorPlace A Look Into Healthcare Sector Value Stocks March 11, 2024 Via Benzinga Overview Of Value Stocks In The Healthcare Sector February 12, 2024 Via Benzinga Syros Pharmaceuticals: Q1 Earnings Insights May 10, 2023 Via Benzinga Syros Pharmaceuticals's Earnings Outlook May 09, 2023 Via Benzinga Syros Pharmaceuticals's Return On Capital Employed Overview March 08, 2023 Via Benzinga Earnings Scheduled For March 27, 2024 March 27, 2024 Companies Reporting Before The Bell • Local Bounti (NYSE:LOCL) is projected to report quarterly loss at $2.41 per share on revenue of $8.70 million. Via Benzinga 3 Once-in-a-Lifetime Penny Stocks With Unprecedented Surge Potential January 31, 2024 Is your portfolio is in dire need of making new all-time highs? A new economic cycle is to send these penny stocks with potential up. Via InvestorPlace 5 Value Stocks To Watch In The Healthcare Sector January 29, 2024 Via Benzinga 12 Health Care Stocks Moving In Tuesday's After-Market Session January 09, 2024 Via Benzinga 5 Value Stocks To Watch In The Healthcare Sector January 01, 2024 Via Benzinga 12 Health Care Stocks Moving In Tuesday's After-Market Session December 19, 2023 Via Benzinga Why Is Blood Cancer Focused Syros Pharmaceuticals Stock Soaring Today? December 06, 2023 Syros Pharmaceuticals Inc (NASDAQ: SYRS) released initial data from its ongoing SELECT-AML-1 Phase 2 trial of tamibarotene in combination with venetoclax and azacitidine in newly diagnosed, unfit... Via Benzinga 12 Health Care Stocks Moving In Wednesday's Intraday Session December 06, 2023 Via Benzinga Small Stakes, Big Rewards: 3 Penny Stocks with 300% Upside Potential December 03, 2023 Although even so-called penny stocks with potential carry dramatic risks, these four-baggers benefit from analyst backing. Via InvestorPlace 12 Health Care Stocks Moving In Friday's After-Market Session October 20, 2023 Via Benzinga 12 Health Care Stocks Moving In Monday's Intraday Session October 02, 2023 Via Benzinga 12 Health Care Stocks Moving In Friday's After-Market Session August 11, 2023 Via Benzinga Pfizer To Terminate Development Pact With Syros Pharmaceuticals For Novel Therapies For Two Blood Disorders July 24, 2023 Syros Pharmaceuticals Inc received notice from Pfizer Inc (NYSE: PFE), as successor to Global Blood Therapeutics Inc, exercising its right to terminate the License and Collaboration Agreement dated... Via Benzinga 12 Health Care Stocks Moving In Tuesday's Pre-Market Session April 04, 2023 Via Benzinga Stocks That Hit 52-Week Lows On Friday March 31, 2023 On Friday, 93 stocks made new 52-week lows. Via Benzinga Tesla To Rally Around 15%? Here Are 10 Other Analyst Forecasts For Friday March 03, 2023 Credit Suisse cut the price target for Hormel Foods Corporation (NYSE: HRL) from $44 to $41. Credit Suisse analyst Robert Moskow maintained a Neutral rating. Hormel Foods shares fell 1.7% to $41.13 in... Via Benzinga < Previous 1 2 3 4 5 6 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.